SCHEMBL4411218

SCHEMBL4411218

CCCC(NC(=O)N1CC(OC(c2ccc(Cl)cc2)c2ccccc2Cl)C1)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
FAAH O00519 16/20 0.49
CNR1 P21554 2/20 0.47
CNR2 P34972 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4406000 0.87 FAAH (0.44) FAAHCNR1CNR2
SCHEMBL4082474 0.86 FAAH (0.49) FAAHCNR1CNR2
SCHEMBL4084842 0.85 FAAH (0.53) FAAHCNR1CNR2
SCHEMBL4075866 0.85 FAAH (0.53) FAAHCNR1CNR2
SCHEMBL4082480 0.85 FAAH (0.48) FAAHCNR1CNR2
SCHEMBL4075585 0.84 GRIN2B (0.56) FAAHCNR1CNR2
SCHEMBL4078365 0.83 FAAH (0.51) FAAHCNR1CNR2
SCHEMBL5818620 0.83 FAAH (0.50) FAAHCNR1CNR2
SCHEMBL4083275 0.82 FAAH (0.52) FAAHCNR1CNR2
SCHEMBL4079582 0.82 FAAH (0.45) FAAHCNR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1620395-B1 AZETIDINECARBOXAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CB1 RECEPTOR MEDIATED DISORDERS VERNALIS RES LTD (GB) 2009-12-30 EP claimed